Skip to main content
Erschienen in:

01.02.2017 | Palliativmedizin

Palliative Therapie der Atemnot bei fortgeschrittenen Erkrankungen

verfasst von: Univ.-Prof. Dr. Claudia Bausewein, PhD, M.Sc.

Erschienen in: Wiener klinisches Magazin | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Zusammenfassung

Hintergrund

Atemnot ist ein häufiges und belastendes Symptom bei fortgeschrittenen Erkrankungen. Sie beeinträchtigt die Lebensqualität der Patienten und ihrer Angehörigen erheblich.

Ziel der Arbeit

Auf Basis der vorhandenen Evidenz werden die nichtmedikamentösen und medikamentösen Behandlungsoptionen für Atemnot zusammengefasst.

Material und Methoden

Es wurden Primärstudien, Übersichtsarbeiten und Leitlinien zu den genannten Symptomen und deren Behandlung ausgewertet.

Ergebnisse

Wichtig für die Behandlung der Atemnot sind zunächst das Erkennen und die Evaluation. Zur Therapie stehen nichtmedikamentöse und medikamentöse Maßnahmen zur Verfügung, die in der Regel miteinander kombiniert werden sollten. Allgemeine Informationen, ein Plan zum Umgang mit Atemnot, der Einsatz eines Handventilators, körperliche Aktivität und Rollatoren gehören zu den nichtmedikamentösen Maßnahmen. Opioide sind Medikamente der ersten Wahl für eine therapierefraktäre Atemnot. In Bezug auf Benzodiazepine und andere Medikamente ist die Evidenz nur gering.

Schlussfolgerung

Für die Behandlung der Atemnot gibt es eine Reihe von Therapieoptionen, die dem Patienten besonders im nichtmedikamentösen Bereich helfen, besser mit der Atemnot zurechtzukommen.
Literatur
1.
Zurück zum Zitat Moens K, Higginson IJ, Harding R (2014) Are there differences in the prevalence of palliative care-related problems in people living with advanced cancer and eight non-cancer conditions? A systematic review. J Pain Symptom Manage 48(4):660–677CrossRefPubMed Moens K, Higginson IJ, Harding R (2014) Are there differences in the prevalence of palliative care-related problems in people living with advanced cancer and eight non-cancer conditions? A systematic review. J Pain Symptom Manage 48(4):660–677CrossRefPubMed
2.
Zurück zum Zitat Currow DC, Plummer JL, Crockett A, Abernethy AP (2009) A community population survey of prevalence and severity of dyspnea in adults. J Pain Symptom Manage 38(4):533–545CrossRefPubMed Currow DC, Plummer JL, Crockett A, Abernethy AP (2009) A community population survey of prevalence and severity of dyspnea in adults. J Pain Symptom Manage 38(4):533–545CrossRefPubMed
3.
Zurück zum Zitat Lopez Varela MV, Montes de Oca M, Halbert RJ, Muino A, Perez-Padilla R, Talamo C et al (2010) Sex-related differences in COPD in five Latin American cities: the PLATINO study. Eur Respir J 36(5):1034–1041CrossRefPubMed Lopez Varela MV, Montes de Oca M, Halbert RJ, Muino A, Perez-Padilla R, Talamo C et al (2010) Sex-related differences in COPD in five Latin American cities: the PLATINO study. Eur Respir J 36(5):1034–1041CrossRefPubMed
4.
Zurück zum Zitat Figarska SM, Boezen HM, Vonk JM (2012) Dyspnea severity, changes in dyspnea status and mortality in the general population: the Vlagtwedde/Vlaardingen study. Eur J Epidemiol 27(11):867–876CrossRefPubMedPubMedCentral Figarska SM, Boezen HM, Vonk JM (2012) Dyspnea severity, changes in dyspnea status and mortality in the general population: the Vlagtwedde/Vlaardingen study. Eur J Epidemiol 27(11):867–876CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Kessler R, Partridge MR, Miravitlles M, Cazzola M, Vogelmeier C, Leynaud D et al (2011) Symptom variability in patients with severe COPD: a pan-European cross-sectional study. Eur Respir J 37(2):264–272CrossRefPubMed Kessler R, Partridge MR, Miravitlles M, Cazzola M, Vogelmeier C, Leynaud D et al (2011) Symptom variability in patients with severe COPD: a pan-European cross-sectional study. Eur Respir J 37(2):264–272CrossRefPubMed
6.
Zurück zum Zitat Parshall MB, Schwartzstein RM, Adams L, Banzett RB, Manning HL, Bourbeau J et al (2012) An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 185(4):435–452CrossRefPubMed Parshall MB, Schwartzstein RM, Adams L, Banzett RB, Manning HL, Bourbeau J et al (2012) An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 185(4):435–452CrossRefPubMed
7.
Zurück zum Zitat Lansing RW, Gracely RH, Banzett RB (2009) The multiple dimensions of dyspnea: review and hypotheses. Respir Physiol Neurobiol 167(1):53–60CrossRefPubMed Lansing RW, Gracely RH, Banzett RB (2009) The multiple dimensions of dyspnea: review and hypotheses. Respir Physiol Neurobiol 167(1):53–60CrossRefPubMed
8.
Zurück zum Zitat Abernethy AP, Currow DC, Frith P, Fazekas BS, McHugh A, Bui C (2003) Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ 327(7414):523–528CrossRefPubMedPubMedCentral Abernethy AP, Currow DC, Frith P, Fazekas BS, McHugh A, Bui C (2003) Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ 327(7414):523–528CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Simon ST, Weingartner V, Voltz R, Bausewein C (2014) Atemnotattacken: Ubersetzung und Konsentierung der internationalen Definition im Rahmen einer Delphi-Befragung. Dtsch Med Wochenschr 139(42):2127–2131 ([Episodic breathlessness: translation and consenting of the international definition using the Delphi method])CrossRefPubMed Simon ST, Weingartner V, Voltz R, Bausewein C (2014) Atemnotattacken: Ubersetzung und Konsentierung der internationalen Definition im Rahmen einer Delphi-Befragung. Dtsch Med Wochenschr 139(42):2127–2131 ([Episodic breathlessness: translation and consenting of the international definition using the Delphi method])CrossRefPubMed
10.
Zurück zum Zitat Reddy SK, Parsons HA, Elsayem A, Palmer JL, Bruera E (2009) Characteristics and correlates of dyspnea in patients with advanced cancer. J Palliat Med 12(1):29–36CrossRefPubMed Reddy SK, Parsons HA, Elsayem A, Palmer JL, Bruera E (2009) Characteristics and correlates of dyspnea in patients with advanced cancer. J Palliat Med 12(1):29–36CrossRefPubMed
12.
Zurück zum Zitat Gysels M, Higginson IJ (2008) Access to services for patients with chronic obstructive pulmonary disease: the invisibility of breathlessness. J Pain Symptom Manage 36(5):451–460CrossRefPubMed Gysels M, Higginson IJ (2008) Access to services for patients with chronic obstructive pulmonary disease: the invisibility of breathlessness. J Pain Symptom Manage 36(5):451–460CrossRefPubMed
13.
Zurück zum Zitat Nicholls DA (2003) The experience of breathlessness. Physiother Theory Pract 19:123–126CrossRef Nicholls DA (2003) The experience of breathlessness. Physiother Theory Pract 19:123–126CrossRef
14.
Zurück zum Zitat Booth S, Silvester S, Todd C (2003) Breathlessness in cancer and chronic obstructive pulmonary disease: using a qualitative approach to describe the experience of patients and carers. Palliat Support Care 1(4):337–344CrossRefPubMed Booth S, Silvester S, Todd C (2003) Breathlessness in cancer and chronic obstructive pulmonary disease: using a qualitative approach to describe the experience of patients and carers. Palliat Support Care 1(4):337–344CrossRefPubMed
15.
Zurück zum Zitat Palmer JL, Fisch MJ (2005) Association between symptom distress and survival in outpatients seen in a palliative care cancer center. J Pain Symptom Manage 29(6):565–571CrossRefPubMed Palmer JL, Fisch MJ (2005) Association between symptom distress and survival in outpatients seen in a palliative care cancer center. J Pain Symptom Manage 29(6):565–571CrossRefPubMed
16.
Zurück zum Zitat Nishimura K, Izumi T, Tsukino M, Oga T (2002) Dyspnea is a better predictor of 5‑year survival than airway obstruction in patients with COPD. Chest 121(5):1434–1440CrossRefPubMed Nishimura K, Izumi T, Tsukino M, Oga T (2002) Dyspnea is a better predictor of 5‑year survival than airway obstruction in patients with COPD. Chest 121(5):1434–1440CrossRefPubMed
17.
Zurück zum Zitat Currow DC, Smith J, Davidson PM, Newton PJ, Agar MR, Abernethy AP (2010) Do the trajectories of dyspnea differ in prevalence and intensity by diagnosis at the end of life? A consecutive cohort study. J Pain Symptom Manage 39(4):680–690CrossRefPubMed Currow DC, Smith J, Davidson PM, Newton PJ, Agar MR, Abernethy AP (2010) Do the trajectories of dyspnea differ in prevalence and intensity by diagnosis at the end of life? A consecutive cohort study. J Pain Symptom Manage 39(4):680–690CrossRefPubMed
18.
Zurück zum Zitat Herigstad M, Hayen A, Wiech K, Pattinson KT (2011) Dyspnoea and the brain. Respir Med 105(6):809–817CrossRefPubMed Herigstad M, Hayen A, Wiech K, Pattinson KT (2011) Dyspnoea and the brain. Respir Med 105(6):809–817CrossRefPubMed
19.
Zurück zum Zitat von Leupoldt A, Sommer T, Kegat S, Baumann HJ, Klose H, Dahme B et al (2008) The unpleasantness of perceived dyspnea is processed in the anterior insula and amygdala. Am J Respir Crit Care Med 177(9):1026–1032CrossRef von Leupoldt A, Sommer T, Kegat S, Baumann HJ, Klose H, Dahme B et al (2008) The unpleasantness of perceived dyspnea is processed in the anterior insula and amygdala. Am J Respir Crit Care Med 177(9):1026–1032CrossRef
20.
Zurück zum Zitat Leitlinienprogramm Onkologie. S3 Leitlinie Palliativmedizin für Patienten mit einer nicht heilbaren Krebserkrankung. Onkologie Leitlinienprogramm, 2015 Contract No.: AWMF-Registernummer: 128/001OL Leitlinienprogramm Onkologie. S3 Leitlinie Palliativmedizin für Patienten mit einer nicht heilbaren Krebserkrankung. Onkologie Leitlinienprogramm, 2015 Contract No.: AWMF-Registernummer: 128/001OL
21.
Zurück zum Zitat British Thoracic Society. Concise BTS/ACPRC guidelines Physiotherapy management of the adult, medical, spontaneously breathing patient. 2009 Contract No.: 1 British Thoracic Society. Concise BTS/ACPRC guidelines Physiotherapy management of the adult, medical, spontaneously breathing patient. 2009 Contract No.: 1
22.
Zurück zum Zitat Jolley CJ, Moxham J (2009) A physiological model of patient-reported breathlessness during daily activities in COPD. Eur Respir Rev 18(112):66–79CrossRefPubMed Jolley CJ, Moxham J (2009) A physiological model of patient-reported breathlessness during daily activities in COPD. Eur Respir Rev 18(112):66–79CrossRefPubMed
23.
Zurück zum Zitat Watz H, Pitta F, Rochester CL, Garcia-Aymerich J, ZuWallack R, Troosters T et al (2014) An official European Respiratory Society statement on physical activity in COPD. Eur Respir J 44(6):1521–1537CrossRefPubMed Watz H, Pitta F, Rochester CL, Garcia-Aymerich J, ZuWallack R, Troosters T et al (2014) An official European Respiratory Society statement on physical activity in COPD. Eur Respir J 44(6):1521–1537CrossRefPubMed
24.
Zurück zum Zitat Bausewein C, Booth S, Gysels M, Higginson I (2008) Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane Database Systrev 2:CD005623 Bausewein C, Booth S, Gysels M, Higginson I (2008) Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane Database Systrev 2:CD005623
25.
Zurück zum Zitat Probst VS, Troosters T, Coosemans I, Spruit MA, Pitta FO, Decramer M et al (2004) Mechanisms of improvement in exercise capacity using a rollator in patients with COPD. Chest 126(4):1102–1107CrossRefPubMed Probst VS, Troosters T, Coosemans I, Spruit MA, Pitta FO, Decramer M et al (2004) Mechanisms of improvement in exercise capacity using a rollator in patients with COPD. Chest 126(4):1102–1107CrossRefPubMed
26.
Zurück zum Zitat Booth S, Moffat C, Burkin J, Galbraith S, Bausewein C (2011) Nonpharmacological interventions for breathlessness. Curr Opin Support Palliat Care 5(2):77–86CrossRefPubMed Booth S, Moffat C, Burkin J, Galbraith S, Bausewein C (2011) Nonpharmacological interventions for breathlessness. Curr Opin Support Palliat Care 5(2):77–86CrossRefPubMed
27.
Zurück zum Zitat Galbraith S, Fagan P, Perkins P, Lynch A, Booth S (2010) Does the use of a handheld fan improve chronic dyspnea? A randomized, controlled, crossover trial. J Pain Symptom Manage 39(5):831–838CrossRefPubMed Galbraith S, Fagan P, Perkins P, Lynch A, Booth S (2010) Does the use of a handheld fan improve chronic dyspnea? A randomized, controlled, crossover trial. J Pain Symptom Manage 39(5):831–838CrossRefPubMed
28.
Zurück zum Zitat Higginson IJ, Bausewein C, Reilly CC, Gao W, Gysels M, Dzingina M et al (2014) An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness: a randomised controlled trial. Lancet Respir Med 2(12):979–987CrossRefPubMed Higginson IJ, Bausewein C, Reilly CC, Gao W, Gysels M, Dzingina M et al (2014) An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness: a randomised controlled trial. Lancet Respir Med 2(12):979–987CrossRefPubMed
29.
Zurück zum Zitat Farquhar MC, Prevost A, McCrone P, Brafman-Price B, Bentley A, Higginson IJ et al (2014) Is a specialist breathlessness service more effective and cost-effective for patients with advanced cancer and their carers than standard care? Findings of a mixed-method randomised controlled trial. BMC Med 12(1):194CrossRefPubMedPubMedCentral Farquhar MC, Prevost A, McCrone P, Brafman-Price B, Bentley A, Higginson IJ et al (2014) Is a specialist breathlessness service more effective and cost-effective for patients with advanced cancer and their carers than standard care? Findings of a mixed-method randomised controlled trial. BMC Med 12(1):194CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Simon ST, Higginson IJ, Booth S, Harding R, Bausewein C (2010) Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database Syst Rev 1:CD007354–2010 Simon ST, Higginson IJ, Booth S, Harding R, Bausewein C (2010) Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database Syst Rev 1:CD007354–2010
31.
Zurück zum Zitat Barnes H, McDonald J, Smallwood N, Manser R (2016) Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness. Cochrane Database Syst Rev 3:CD011008PubMed Barnes H, McDonald J, Smallwood N, Manser R (2016) Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness. Cochrane Database Syst Rev 3:CD011008PubMed
32.
Zurück zum Zitat Ekstrom M, Nilsson F, Abernethy AA, Currow DC (2015) Effects of opioids on breathlessness and exercise capacity in chronic obstructive pulmonary disease. A systematic review. Ann Am Thorac Soc 12(7):1079–1092CrossRefPubMed Ekstrom M, Nilsson F, Abernethy AA, Currow DC (2015) Effects of opioids on breathlessness and exercise capacity in chronic obstructive pulmonary disease. A systematic review. Ann Am Thorac Soc 12(7):1079–1092CrossRefPubMed
33.
Zurück zum Zitat Johnson MJ, Bland JM, Oxberry SG, Abernethy AP, Currow DC (2013) Opioids for chronic refractory breathlessness: patient predictors of beneficial response. Eur Respir J 42(3):758–766CrossRefPubMed Johnson MJ, Bland JM, Oxberry SG, Abernethy AP, Currow DC (2013) Opioids for chronic refractory breathlessness: patient predictors of beneficial response. Eur Respir J 42(3):758–766CrossRefPubMed
34.
Zurück zum Zitat Smallwood N, Le B, Currow D, Irving L, Philip J (2015) Management of refractory breathlessness with morphine in patients with chronic obstructive pulmonary disease. Intern Med J 45(9):898–904CrossRefPubMed Smallwood N, Le B, Currow D, Irving L, Philip J (2015) Management of refractory breathlessness with morphine in patients with chronic obstructive pulmonary disease. Intern Med J 45(9):898–904CrossRefPubMed
35.
Zurück zum Zitat Currow DC, McDonald C, Oaten S, Kenny B, Allcroft P, Frith P et al (2011) Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study. J Pain Symptom Manage 42(3):388–399CrossRefPubMed Currow DC, McDonald C, Oaten S, Kenny B, Allcroft P, Frith P et al (2011) Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study. J Pain Symptom Manage 42(3):388–399CrossRefPubMed
36.
Zurück zum Zitat Lopez-Saca JM, Centeno C (2014) Opioids prescription for symptoms relief and the impact on respiratory function: updated evidence. Curr Opin Support Palliat Care 8(4):383–390CrossRefPubMed Lopez-Saca JM, Centeno C (2014) Opioids prescription for symptoms relief and the impact on respiratory function: updated evidence. Curr Opin Support Palliat Care 8(4):383–390CrossRefPubMed
37.
Zurück zum Zitat Smoller JW, Pollack MH, Systrom D, Kradin RL (1998) Sertraline effects on dyspnea in patients with obstructive airways disease. Psychosomatics 39(1):24–29CrossRefPubMed Smoller JW, Pollack MH, Systrom D, Kradin RL (1998) Sertraline effects on dyspnea in patients with obstructive airways disease. Psychosomatics 39(1):24–29CrossRefPubMed
38.
Zurück zum Zitat Booth S, Bausewein C, Higginson IJ, Moosavi SH (2009) Pharmacological treatment of refractory breathlessness. Expert Rev Respir Med 3(1):21–36CrossRefPubMed Booth S, Bausewein C, Higginson IJ, Moosavi SH (2009) Pharmacological treatment of refractory breathlessness. Expert Rev Respir Med 3(1):21–36CrossRefPubMed
39.
Zurück zum Zitat Magnussen H, Kirsten AM, Köhler D, Morr H, Sitter H, Worth H (2008) Leitlinien zur Langzeit-Sauerstofftherapie. Pneumologe 62:748–756CrossRef Magnussen H, Kirsten AM, Köhler D, Morr H, Sitter H, Worth H (2008) Leitlinien zur Langzeit-Sauerstofftherapie. Pneumologe 62:748–756CrossRef
40.
Zurück zum Zitat Uronis HE, Currow DC, McCrory DC, Samsa GP, Abernethy AP (2008) Oxygen for relief of dyspnoea in mildly- or non-hypoxaemic patients with cancer: a systematic review and meta-analysis. Br J Cancer 98(2):294–299CrossRefPubMedPubMedCentral Uronis HE, Currow DC, McCrory DC, Samsa GP, Abernethy AP (2008) Oxygen for relief of dyspnoea in mildly- or non-hypoxaemic patients with cancer: a systematic review and meta-analysis. Br J Cancer 98(2):294–299CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat Abernethy AP, McDonald CF, Frith PA, Clark K, Herndon JE 2nd, Marcello J et al (2010) Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial. Lancet 376(9743):784–793CrossRefPubMedPubMedCentral Abernethy AP, McDonald CF, Frith PA, Clark K, Herndon JE 2nd, Marcello J et al (2010) Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial. Lancet 376(9743):784–793CrossRefPubMedPubMedCentral
Metadaten
Titel
Palliative Therapie der Atemnot bei fortgeschrittenen Erkrankungen
verfasst von
Univ.-Prof. Dr. Claudia Bausewein, PhD, M.Sc.
Publikationsdatum
01.02.2017
Verlag
Springer Vienna
Erschienen in
Wiener klinisches Magazin / Ausgabe 1/2017
Print ISSN: 1869-1757
Elektronische ISSN: 1613-7817
DOI
https://doi.org/10.1007/s00740-016-0156-8

Weitere Artikel der Ausgabe 1/2017

Wiener klinisches Magazin 1/2017 Zur Ausgabe

Panorama

Panorama